RADIAL ANALYTICS INC — National Science Foundation SBIR Phase II: BC

RADIAL ANALYTICS INC — SBIR Phase II award from National Science Foundation.

Phase II SBIR prototype / development signal

  • Phase II is where National Science Foundation funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • Obligated amount $750,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Topic code BC links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Amount
$750,000
Agency
National Science Foundation
Program / Phase
SBIR · Phase II
Topic
BC
NAICS
Place of performance
MA
Period
2015-09-13 → 2017-08-31

Description

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is significant; transitions of care impact millions of Americans every year. The healthcare system bears substantial cost and inefficiency
on account of suboptimal care transitions and overspending. This Phase II project will support progress towards a "learning healthcare system" and will extend the capabilities of data mining and machine learning in healthcare The proposed project seeks to improve data mining technologies for healthcare decision support. This project will focus on the analysis of a broad variety
of data types that are common in healthcare settings. The anticipated improvements would allow frontline care staff, operational managers, and healthcare executives to assess and make stronger evidence-driven decisions regarding quality, cost, and access as patients move through the healthcare system. The enhanced data mining system would utilize state-of-the-art pattern recognition and machine learning techniques to dynamically process and interpret clinical, claims, and other types of healthcare data. If successful, this research will impact the state-of-the-art in healthcare analytics.